Eventide Healthcare & Life Sciences Fund Class A Shares logo

Eventide Healthcare & Life Sciences Fund Class A Shares (ETAHX)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
55. 12
+1.05
+1.9419%
$
1.74B Market Cap
2.46% Div Yield
0 Volume
$ 54.07
Previous Close
Add Transaction
Day Range
55.12 55.12
Year Range
33.38 58.13
Want to track ETAHX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ETAHX closed today higher at $55.12, an increase of 1.9419% from yesterday's close, completing a monthly decrease of -1.5538% or -$0.87. Over the past 12 months, ETAHX stock gained 10.7494%.
ETAHX pays dividends to its shareholders, with the most recent payment made on Dec 17, 2021. The next estimated payment will be in 17 Dec 2021 on Dec 17, 2021 for a total of $4.3473.
The stock of the company had never split.
The company's stock is traded on one exchange.

ETAHX Chart

People also search for

Nurix Therapeutics Inc.
$ 23.12
+0.2167%
Urogen Pharma Ltd.
$ 40.23
+0.575%
GH Research plc
$ 28.71
-1.4418%
Maze Therapeutics Inc.
$ 28.12
+3.5156%
Intellia Therapeutics Inc.
$ 11.38
-4.0894%

Eventide Healthcare & Life Sciences Fund Class A Shares (ETAHX) FAQ

What is the stock price today?

The current price is $55.12.

On which exchange is it traded?

Eventide Healthcare & Life Sciences Fund Class A Shares is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is ETAHX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.46%.

What is its market cap?

As of today, the market cap is 1.74B.

Has Eventide Healthcare & Life Sciences Fund Class A Shares ever had a stock split?

No, there has never been a stock split.

Eventide Healthcare & Life Sciences Fund Class A Shares Profile

NASDAQ (NMS) Exchange
US Country

Overview

The fund is primarily focused on the healthcare and life sciences sectors, aiming to invest a considerable portion of its assets in equity and equity-related securities within these domains. This includes a wide array of investment vehicles such as common stock, options, preferred stock, and convertible debt, showing a versatile approach to capturing value across different financial instruments. The fund's strategy is not geographically limited to the United States, as it actively seeks investment opportunities globally. This is facilitated through direct investments and the use of American Depositary Receipts (ADRs), enabling participation in the performance of non-U.S. companies. The fund is designed to be adaptable in terms of the market capitalization of the companies it invests in, indicating a flexible investment approach that can span from small-cap to large-cap companies.

Products and Services

  • Equity Investments
  • Primarily investing in equity securities of companies within the healthcare and life sciences sectors. This forms the core of the fund's investment strategy, targeting companies that show potential for growth or value addition in these rapidly evolving industries.

  • Equity-Related Securities
  • The fund extends its investment reach to equity-related securities, including options, preferred stock, and convertible debt. This diversified approach allows the fund to leverage different financial instruments to maximize returns from its focus industries.

  • Global Investment
  • Investment is not confined to U.S. based companies; the fund actively seeks opportunities globally. This is achieved through both direct investments in foreign companies and the use of American Depositary Receipts (ADRs), providing a broader investment horizon and access to global healthcare and life sciences markets.

  • Flexible Market Capitalization
  • The fund shows flexibility in the market capitalization of the companies in which it invests, meaning it considers investments across small, mid, and large-cap companies. This approach allows the fund to explore a wide range of investment opportunities and adapt its portfolio according to the prevailing market conditions and potential growth prospects.

Contact Information

Address: C/O Gemini Fund Services LLC
Phone: 866-447-4228